Cheryl Vernon

1.6k total citations
16 papers, 1.2k citations indexed

About

Cheryl Vernon is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Cheryl Vernon has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Pulmonary and Respiratory Medicine and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Cheryl Vernon's work include Sarcoma Diagnosis and Treatment (6 papers), Medical Imaging Techniques and Applications (6 papers) and Cardiac tumors and thrombi (5 papers). Cheryl Vernon is often cited by papers focused on Sarcoma Diagnosis and Treatment (6 papers), Medical Imaging Techniques and Applications (6 papers) and Cardiac tumors and thrombi (5 papers). Cheryl Vernon collaborates with scholars based in United States, Ireland and Germany. Cheryl Vernon's co-authors include Janet F. Eary, Ernest U. Conrad, Scott M. Schuetze, Douglas S. Hawkins, James D. Bruckner, F R Appelbaum, Stephen H. Petersdorf, Joseph G. Rajendran, Winfried Brenner and Brian P. Rubin and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of Bone and Joint Surgery.

In The Last Decade

Cheryl Vernon

16 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheryl Vernon United States 12 716 605 371 249 222 16 1.2k
Colleen M. Costelloe United States 19 667 0.9× 617 1.0× 377 1.0× 322 1.3× 102 0.5× 55 1.3k
Henrik Petersen Denmark 23 528 0.7× 623 1.0× 173 0.5× 282 1.1× 160 0.7× 59 1.5k
Eugenio Salizzoni Italy 18 500 0.7× 385 0.6× 327 0.9× 191 0.8× 54 0.2× 27 1.4k
Robert Mansberg Australia 15 388 0.5× 333 0.6× 185 0.5× 191 0.8× 98 0.4× 108 843
Akmal Safwat Denmark 22 925 1.3× 282 0.5× 676 1.8× 229 0.9× 241 1.1× 82 1.6k
S N Reske Germany 10 584 0.8× 699 1.2× 208 0.6× 102 0.4× 57 0.3× 21 1.2k
Sarat Chander Australia 20 1.1k 1.6× 349 0.6× 429 1.2× 507 2.0× 47 0.2× 72 1.7k
Gerard Powell Australia 14 468 0.7× 114 0.2× 527 1.4× 187 0.8× 59 0.3× 27 959
A. N. Serafini United States 13 384 0.5× 508 0.8× 552 1.5× 402 1.6× 27 0.1× 29 1.2k
Maurizio Portaluri Italy 15 246 0.3× 290 0.5× 329 0.9× 151 0.6× 315 1.4× 59 937

Countries citing papers authored by Cheryl Vernon

Since Specialization
Citations

This map shows the geographic impact of Cheryl Vernon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Vernon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Vernon more than expected).

Fields of papers citing papers by Cheryl Vernon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Vernon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Vernon. The network helps show where Cheryl Vernon may publish in the future.

Co-authorship network of co-authors of Cheryl Vernon

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl Vernon. A scholar is included among the top collaborators of Cheryl Vernon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl Vernon. Cheryl Vernon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Brenner, Winfried, et al.. (2006). Risk assessment in liposarcoma patients based on FDG PET imaging. European Journal of Nuclear Medicine and Molecular Imaging. 33(11). 1290–1295. 64 indexed citations
2.
Hawkins, Douglas S., Scott M. Schuetze, James E. Butrynski, et al.. (2005). [18F]Fluorodeoxyglucose Positron Emission Tomography Predicts Outcome for Ewing Sarcoma Family of Tumors. Journal of Clinical Oncology. 23(34). 8828–8834. 193 indexed citations
3.
Schuetze, Scott M., Janet F. Eary, Kathleen A. Griffith, et al.. (2005). FDG PET but not RECIST agrees with histologic response of soft tissue sarcoma to neoadjuvant chemotherapy. Journal of Clinical Oncology. 23(16_suppl). 9005–9005. 11 indexed citations
4.
Schuetze, Scott M., Brian P. Rubin, Cheryl Vernon, et al.. (2004). Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy. Cancer. 103(2). 339–348. 164 indexed citations
5.
Brenner, Winfried, Cheryl Vernon, Mark Muzi, et al.. (2004). Comparison of different quantitative approaches to 18F-fluoride PET scans.. PubMed. 45(9). 1493–500. 73 indexed citations
6.
Brenner, Winfried, et al.. (2004). Assessment of the metabolic activity of bone grafts with 18F-fluoride PET. European Journal of Nuclear Medicine and Molecular Imaging. 31(9). 1291–8. 39 indexed citations
7.
O’Sullivan, Finbarr, et al.. (2004). An examination of the statistical reliability and prognostic potential of a measure of 3D spatial heterogeneity developed for volumetric PET images of human sarcomas. 2002 IEEE Nuclear Science Symposium Conference Record. 2. 1131–1134. 1 indexed citations
8.
Conrad, Ernest U., Hannah Morgan, Cheryl Vernon, Scott M. Schuetze, & Janet F. Eary. (2004). Fluorodeoxyglucose Positron Emission Tomography Scanning. Journal of Bone and Joint Surgery. 86. 98–104. 13 indexed citations
9.
Vernon, Cheryl, Janet F. Eary, Brian P. Rubin, Ernest U. Conrad, & Scott M. Schuetze. (2003). FDG PET imaging guided re-evaluation of histopathologic response in a patient with high-grade sarcoma. Skeletal Radiology. 32(3). 139–142. 14 indexed citations
10.
Eary, Janet F., et al.. (2002). Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis. European Journal of Nuclear Medicine and Molecular Imaging. 29(9). 1149–1154. 149 indexed citations
11.
Wells, Joanne M., David A. Mankoff, Janet F. Eary, et al.. (2002). Kinetic Analysis of 2-[<SUP>11</SUP>C]Thymidine PET Imaging Studies of Malignant Brain Tumors: Preliminary Patient Results. Molecular Imaging. 1(3). 145–150. 26 indexed citations
12.
Wells, Joanne M., David A. Mankoff, Janet F. Eary, et al.. (2002). Kinetic Analysis of 2-[11C]Thymidine PET Imaging Studies of Malignant Brain Tumors: Preliminary Patient Results. Molecular Imaging. 1(3). 4 indexed citations
13.
Rajendran, Joseph G., et al.. (2002). High-dose 166Ho-DOTMP in myeloablative treatment of multiple myeloma: pharmacokinetics, biodistribution, and absorbed dose estimation.. PubMed. 43(10). 1383–90. 44 indexed citations
14.
Littlewood, Timothy J., Cheryl Vernon, Paul Wilkinson, et al.. (2000). PCH2: THE LEVEL OF HAEMOGLOBIN (Hb) IN U.K. CANCER PATIENTS CORRELATES POSITIVELY WITH QUALITY OF LIFE (QoL). Value in Health. 3(5). 350–351. 2 indexed citations
15.
Collins, C. B., Janet F. Eary, Gary Donaldson, et al.. (1993). Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial.. PubMed. 34(11). 1839–44. 197 indexed citations
16.
Eary, Janet F., Conor D. Collins, Michael Stabin, et al.. (1993). Samarium-153-EDTMP biodistribution and dosimetry estimation.. PubMed. 34(7). 1031–6. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026